| Q41847635 | A bacterial encoded protein induces extreme multinucleation and cell-cell internalization in intestinal cells |
| Q37260988 | Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host |
| Q35714579 | Allele- and tir-independent functions of intimin in diverse animal infection models |
| Q33616699 | Analysis of the virulence of an atypical enteropathogenic Escherichia coli strain in vitro and in vivo and the influence of type three secretion system |
| Q64117917 | Aqueous extract of Hibiscus sabdariffa inhibits pedestal induction by enteropathogenic E. coli and promotes bacterial filamentation in vitro |
| Q40154538 | Association of Atypical Enteropathogenic Escherichia coli with Diarrhea and Related Mortality in Kittens |
| Q52569423 | Attaching and effacing pathogen-induced tight junction disruption in vivo. |
| Q33528372 | Bacterial guanine nucleotide exchange factors SopE-like and WxxxE effectors |
| Q57374189 | Bacterial-associated cholera toxin and GM1 binding are required for transcytosis of classical biotype Vibrio cholerae through an in vitro M cell model system |
| Q38325835 | Cell-surface nucleolin is sequestered into EPEC microcolonies and may play a role during infection |
| Q40270542 | Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map). |
| Q36938473 | Concepts and mechanisms: crossing host barriers |
| Q90376721 | Coordinated transient interaction of ZO-1 and afadin is required for pedestal maturation induced by EspF from enteropathogenic Escherichia coli |
| Q38816242 | Cultured enterocytes internalise bacteria across their basolateral surface for, pathogen-inhibitable, trafficking to the apical compartment |
| Q39802987 | Disruption of transepithelial resistance by enterotoxigenic Escherichia coli |
| Q39413863 | Do Caco-2 subclones provide more appropriate in vitro models for understanding how human enteric pathogens cause disease? |
| Q50002272 | Dynamic monitoring of Salmonella typhimurium infection of polarized epithelia using organic transistors |
| Q38724200 | EPEC effector EspF promotes Crumbs3 endocytosis and disrupts epithelial cell polarity |
| Q53845870 | Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. |
| Q52688929 | Enteropathogenic E. coli effectors EspF and Map independently disrupt tight junctions through distinct mechanisms involving transcriptional and post-transcriptional regulation. |
| Q41506828 | Enteropathogenic E. coli effectors EspG1/G2 disrupt microtubules, contribute to tight junction perturbation and inhibit restoration |
| Q38021502 | Enteropathogenic E. coli effectors EspG1/G2 disrupt tight junctions: new roles and mechanisms |
| Q35890719 | Enteropathogenic E. coli-induced barrier function alteration is not a consequence of host cell apoptosis |
| Q26996996 | Enteropathogenic E. coli: breaking the intestinal tight junction barrier |
| Q92702710 | Enteropathogenic Escherichia coli (EPEC) Recruitment of PAR Polarity Protein Atypical PKCζ to Pedestals and Cell-Cell Contacts Precedes Disruption of Tight Junctions in Intestinal Epithelial Cells |
| Q54474693 | Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. |
| Q40153854 | Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. |
| Q55605885 | Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations. |
| Q37034994 | Enteropathogenic Escherichia coli subverts phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate upon epithelial cell infection |
| Q42988754 | Enteropathogenic Escherichia coli type III effectors EspG and EspG2 alter epithelial paracellular permeability |
| Q41851259 | Enteropathogenic Escherichia coli, Shigella flexneri, and Listeria monocytogenes recruit a junctional protein, zonula occludens-1, to actin tails and pedestals. |
| Q34177961 | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements |
| Q36104202 | Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation |
| Q37501404 | Escherichia coli challenge and one type of smectite alter intestinal barrier of pigs |
| Q41878712 | EspA-Intimin chimeric protein, a candidate vaccine against Escherichia coli O157:H7. |
| Q93103591 | EspF is crucial for Citrobacter rodentium-induced tight junction disruption and lethality in immunocompromised animals |
| Q91817427 | Establishing Boundaries: The Relationship That Exists between Intestinal Epithelial Cells and Gut-Dwelling Bacteria |
| Q34995443 | Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen |
| Q35217574 | Evidence that tight junctions are disrupted due to intimate bacterial contact and not inflammation during attaching and effacing pathogen infection in vivo |
| Q30276039 | Evolution of atypical enteropathogenic E. coli by repeated acquisition of LEE pathogenicity island variants |
| Q48062641 | Evolutionary analysis and distribution of type III effector genes in pathogenic Escherichia coli from human, animal and food sources |
| Q34889643 | Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo |
| Q38830802 | Generation of a MDCK cell line with constitutive expression of the Enteropathogenic E. coli effector protein Map as an in vitro model of pathogenesis. |
| Q35733648 | Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid. |
| Q34679342 | Human Intestinal Barrier Function in Health and Disease |
| Q35503745 | Impenetrable barriers or entry portals? The role of cell-cell adhesion during infection |
| Q38086226 | In vitro and in vivo model systems for studying enteropathogenic Escherichia coli infections |
| Q38007348 | Infection strategies of enteric pathogenic Escherichia coli |
| Q34576318 | Insights into the pathogenesis of enteropathogenic E. coli using an improved intestinal enterocyte model |
| Q27012975 | Interspecies communication in the gut, from bacterial delivery to host-cell response |
| Q25257684 | Listeria monocytogenes invades the epithelial junctions at sites of cell extrusion |
| Q52691745 | Modulation of Intestinal Paracellular Transport by Bacterial Pathogens. |
| Q39382722 | Modulation of epithelial cell polarity by bacterial pathogens |
| Q36421582 | Modulation of intestinal goblet cell function during infection by an attaching and effacing bacterial pathogen |
| Q33907548 | NOD-like receptors in intestinal homeostasis and epithelial tissue repair |
| Q30009263 | Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector |
| Q33329537 | Parallels between pathogens and gluten peptides in celiac sprue |
| Q37264192 | Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines |
| Q34478656 | Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins |
| Q37174121 | Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens |
| Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
| Q42115897 | Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium |
| Q34287155 | Regulation of intestinal epithelial permeability by tight junctions. |
| Q43042120 | Retrofitting the battlements: tight junction remodeling as a novel antimicrobial approach |
| Q47262383 | Screening for host proteins interacting with Escherichia coli O157:H7 EspF using bimolecular fluorescence complementation |
| Q36012269 | Synapses: sites of cell recognition, adhesion, and functional specification. |
| Q39013776 | Targeting and alteration of tight junctions by bacteria and their virulence factors such as Clostridium perfringens enterotoxin |
| Q37777278 | The EspF effector, a bacterial pathogen's Swiss army knife |
| Q34571628 | The N-terminal domain of EspF induces host cell apoptosis after infection with enterohaemorrhagic Escherichia coli O157:H7. |
| Q37333343 | The RNA binding protein CsrA is a pleiotropic regulator of the locus of enterocyte effacement pathogenicity island of enteropathogenic Escherichia coli |
| Q41428403 | The Yersinia enterocolitica type 3 secretion system (T3SS) as toolbox for studying the cell biological effects of bacterial Rho GTPase modulating T3SS effector proteins |
| Q28480402 | The bacterial cytoskeleton modulates motility, type 3 secretion, and colonization in Salmonella |
| Q41971348 | The bacterial effectors EspG and EspG2 induce a destructive calpain activity that is kept in check by the co-delivered Tir effector |
| Q39807355 | The bacterial virulence factor NleA is required for the disruption of intestinal tight junctions by enteropathogenic Escherichia coli. |
| Q42145316 | The bacterial virulence factor NleA's involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain |
| Q37164543 | The bacterial virulence factor lymphostatin compromises intestinal epithelial barrier function by modulating rho GTPases |
| Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
| Q34921824 | The effector repertoire of enteropathogenic E. coli: ganging up on the host cell |
| Q28478223 | The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors |
| Q28474712 | The enteropathogenic E. coli effector EspF targets and disrupts the nucleolus by a process regulated by mitochondrial dysfunction |
| Q40282616 | The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting |
| Q34506955 | The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea |
| Q42704912 | The locus of enterocyte effacement-encoded effector proteins all promote enterohemorrhagic Escherichia coli pathogenicity in infant rabbits |
| Q38223244 | The role of epithelial tight junctions involved in pathogen infections |
| Q30480560 | The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. |
| Q28073886 | Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli |
| Q40171429 | Translocation of enteropathogenic Escherichia coli across an in vitro M cell model is regulated by its type III secretion system. |
| Q38735104 | Tricellular Tight Junction Protein Tricellulin Is Targeted by the Enteropathogenic Escherichia coli Effector EspG1, Leading to Epithelial Barrier Disruption. |
| Q38981719 | Type III Secreted Virulence Factors Manipulating Signaling to Actin Dynamics. |
| Q36969851 | Type III secretion systems and disease |
| Q34046896 | Typical and atypical enteropathogenic Escherichia coli bacterial translocation associated with tissue hypoperfusion in rats. |
| Q43297260 | Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis |
| Q27323111 | Visualizing the Translocation and Localization of Bacterial Type III Effector Proteins by Using a Genetically Encoded Reporter System |